KARUNA SHARMA

KARUNA SHARMA


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2017 in The Journal of Obstetrics and Gynecology of India
Verified
Journal Article
Closed access
PDF file
KSKARUNA SHARMA
KARUNA SHARMA
RSRitu Singh
Ritu Singh
MKManisha Kumar
Manisha Kumar
UGUsha Gupta
Usha Gupta
VRVishwajeet Rohil
Vishwajeet Rohil
JBJayashree Bhattacharjee
Jayashree Bhattacharjee

7 November 2015 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
MKManisha Kumar
Manisha Kumar
UGUsha Gupta
Usha Gupta
JBJayashree Bhattacharjee
Jayashree Bhattacharjee
RSRitu Singh
Ritu Singh
SSShalini Singh
Shalini Singh
MRMujeeb U. Rehman
Mujeeb U. Rehman

2 May 2016 in Hypertension in Pregnancy
Verified
Journal Article
Closed access
PDF file
MKManisha Kumar
Manisha Kumar
KSKARUNA SHARMA
KARUNA SHARMA
RSRitu Singh
Ritu Singh
SSShalini Singh
Shalini Singh
VRV. Ravi
V. Ravi
JBJ. Bhattacharya
J. Bhattacharya
Objective: To determine the predictive value of biochemical markers, uterine artery Doppler, and maternal factors in predicting early-onset (EO) and late-onset (LO) pregnancy hypertension. Methodology: All singleton pregnancies between 11 and 13 weeks and 6 days gestation underwent estimation of body mass index (BMI), mean arterial pressure (MAP), uterine artery Doppler pulsatality index (PI, and resistance index), biomarker PAPP-A, and free β-hCG. Women who developed hypertension were treated as cases and normotensives were taken as controls. The cases were further divided into EO and LO hypertension. The comparison was undertaken by appropriate statistical analysis. Results: Pregnancy hypertension was seen in 399 (13.2%) women. EO hypertension was seen in 153 (38.3%), whereas LO was observed in 246 (61.7%). The significant markers for predicting hypertension in pregnancy were maternal age, BMI, MAP, uterine artery Doppler PI, and PAPP-A. A combination of MAP and BMI was a better predictor (sensitivity and specificity 80% and 52%, respectively) than PAPP-A and Doppler combined (sensitivity and specificity 62% and 52%, respectively). When all the above markers were combined, the sensitivity and specificity of the test was 73% and 70%, respectively. EO hypertension was better predicted compared with LO. The negative predictive value (NPV) of the test was above 90%, suggesting that if a woman had the marker below the cutoff, there was more than 90% chance that she would not develop hypertension later in pregnancy. Conclusion: A combination of variables increased the sensitivity and specificity of the test for hypertension in pregnancy. The markers examined were a predictor of EO hypertension, with a high NPV, making it a good screening test.

10 August 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
MKManisha Kumar
Manisha Kumar
SSShalini Singh
Shalini Singh
KSKARUNA SHARMA
KARUNA SHARMA
RSRitu Singh
Ritu Singh
VRV. Ravi
V. Ravi
JBJayanta Bhattacharya
Jayanta Bhattacharya
Aims and objectives: To evaluate the predictive value of first trimester biomarkers and ultrasound in determining adverse fetal outcomes in a low risk Asian population. Material and method: All low risk, singleton pregnancies between 11 and 14 weeks gestation underwent ultrasound with uterine artery Doppler along with PAPP-A and free β-hCG estimation, and were followed till delivery to observe the outcome. The adverse fetal outcomes detected were structural anomaly, aneuploidy, intrauterine growth restriction, preterm birth and stillbirth (SB). Results: Out of 3500 women screened, 417 cases had adverse fetal outcome in the absence of maternal complication, 2151 had normal outcome. Major structural anomaly was detected in first trimester in 17/28 (60.7%) cases. The most important markers for adverse fetal outcome were increased uterine artery pulsatility index (UPI) (p = 0.028, OR 1.5, 95% CI: 1.05–2.38, AUC 0.56) for IUGR, nuchal translucency (p = 0.001, OR 1.7, 95% CI: 1.11–2.77, AUC 0.60) for major anomaly and low PAPP-A (p = 0.017, OR −0.075, 95% CI: 0.87–0.98, AUC 0.621) for SB. Conclusion: UPI, NT and PAPP-A in the first trimester are significant markers of adverse fetal outcome, although the sensitivity and specificity are not high they have a high negative predictive value.

17 August 2017 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
MKManisha Kumar
Manisha Kumar
KSKARUNA SHARMA
KARUNA SHARMA
SSShalini Singh
Shalini Singh
RSRitu Singh
Ritu Singh
ASAbha Singh
Abha Singh
JBJayashree Bhattacharjee
Jayashree Bhattacharjee

1 January 2018 in The Asian Man
Verified
Journal Article
Closed access
PDF file
JMJyoti Mishra
Jyoti Mishra
KSKARUNA SHARMA
KARUNA SHARMA